Managers / Q1 2026
Beryl Capital Management LLC
CIK 0001719307 · 225 AVENUE I, STE 205, REDONDO BEACH, CA, 90277 · 9174461561
Summary
Beryl Capital Management LLC reported $110M in U.S.-listed holdings across 9 positions for Q1 2026.
The portfolio is heavily concentrated: MASI* alone accounts for 35.2% of reported value.
Compared with Q4 2025, the fund opened 8 new positions and exited 14.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 100.0% · $110M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| MASI*MASIMO CORP | NEW | +217.1K | 217.1K | +$39M | $39M |
| 430TERNS PHARMACEUTICALS INC | NEW | +478.8K | 478.8K | +$25M | $25M |
| GLDDGREAT LAKES DREDGE & DOCK CO | NEW | +912.5K | 912.5K | +$16M | $16M |
| DAWNGBXDAY ONE BIOPHARMACEUTICALS I | NEW | +514.1K | 514.1K | +$11M | $11M |
| STKLSUNOPTA INC | NEW | +1.51M | 1.51M | +$10M | $10M |
| ADEAADEIA INC | NEW | +121.1K | 121.1K | +$3M | $3M |
| HNRGHALLADOR ENERGY COMPANY | NEW | +66.5K | 66.5K | +$1M | $1M |
| FB1FARMER BROS CO | NEW | +336.7K | 336.7K | +$427,641 | $427,641 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | MASI*MASIMO CORPhistory → | COM | 35.19% | $39M | 217.1K |
| 2 | 430TERNS PHARMACEUTICALS INChistory → | COM | 23.00% | $25M | 478.8K |
| 3 | GLDDGREAT LAKES DREDGE & DOCK COhistory → | COM | 14.14% | $16M | 912.5K |
| 4 | DAWNGBXDAY ONE BIOPHARMACEUTICALS Ihistory → | COM | 10.05% | $11M | 514.1K |
| 5 | STKLSUNOPTA INChistory → | COM | 8.91% | $10M | 1.51M |
| 6 | WBDWARNER BROS DISCOVERY INChistory → | COM SER A | 4.69% | $5M | 187.4K |
| 7 | ADEAADEIA INChistory → | COM | 2.65% | $3M | 121.1K |
| 8 | FB1FARMER BROS CO | COM | 0.39% | $427,641 | 336.7K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $110M | 9 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $986M | 15 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $52M | 6 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $664M | 28 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $268M | 13 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $443M | 31 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $463M | 30 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $333M | 24 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $82M | 18 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $182M | 20 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $896M | 31 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $397M | 20 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $127M | 17 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $249M | 23 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $942M | 28 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $968M | 53 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $1.6B | 254 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.9B | 375 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.4B | 220 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.1B | 190 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $783M | 207 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $633M | 229 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $556M | 95 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $526M | 56 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $474M | 42 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $620M | 48 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $388M | 29 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $536M | 20 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $544M | 28 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $609M | 30 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.